Logo image of VAS.DE

VOESTALPINE AG (VAS.DE) Stock Fundamental Analysis

FRA:VAS - Deutsche Boerse Ag - AT0000937503 - Common Stock - Currency: EUR

24.94  -0.56 (-2.2%)

Fundamental Rating

4

VAS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 37 industry peers in the Metals & Mining industry. There are concerns on the financial health of VAS while its profitability can be described as average. VAS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

VAS had negative earnings in the past year.
VAS had a positive operating cash flow in the past year.
VAS had positive earnings in 4 of the past 5 years.
VAS had a positive operating cash flow in each of the past 5 years.
VAS.DE Yearly Net Income VS EBIT VS OCF VS FCFVAS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

VAS's Return On Assets of -0.41% is in line compared to the rest of the industry. VAS outperforms 40.54% of its industry peers.
VAS has a Return On Equity (-0.89%) which is comparable to the rest of the industry.
VAS has a Return On Invested Capital (1.40%) which is in line with its industry peers.
VAS had an Average Return On Invested Capital over the past 3 years of 7.41%. This is in line with the industry average of 6.33%.
The last Return On Invested Capital (1.40%) for VAS is well below the 3 year average (7.41%), which needs to be investigated, but indicates that VAS had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.41%
ROE -0.89%
ROIC 1.4%
ROA(3y)4.84%
ROA(5y)2.66%
ROE(3y)11.5%
ROE(5y)6.24%
ROIC(3y)7.41%
ROIC(5y)N/A
VAS.DE Yearly ROA, ROE, ROICVAS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

VAS's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 1.51%, VAS is doing worse than 64.86% of the companies in the same industry.
VAS's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 17.28%, VAS is in line with its industry, outperforming 48.65% of the companies in the same industry.
In the last couple of years the Gross Margin of VAS has declined.
Industry RankSector Rank
OM 1.51%
PM (TTM) N/A
GM 17.28%
OM growth 3Y15.53%
OM growth 5Y-1.04%
PM growth 3Y16.09%
PM growth 5Y-27.48%
GM growth 3Y-0.15%
GM growth 5Y-3.98%
VAS.DE Yearly Profit, Operating, Gross MarginsVAS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VAS is destroying value.
The number of shares outstanding for VAS has been reduced compared to 1 year ago.
VAS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, VAS has a worse debt to assets ratio.
VAS.DE Yearly Shares OutstandingVAS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VAS.DE Yearly Total Debt VS Total AssetsVAS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.20 indicates that VAS is not a great score, but indicates only limited risk for bankruptcy at the moment.
VAS's Altman-Z score of 2.20 is fine compared to the rest of the industry. VAS outperforms 67.57% of its industry peers.
The Debt to FCF ratio of VAS is 9.89, which is on the high side as it means it would take VAS, 9.89 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of VAS (9.89) is comparable to the rest of the industry.
VAS has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
VAS has a Debt to Equity ratio of 0.35. This is comparable to the rest of the industry: VAS outperforms 43.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 9.89
Altman-Z 2.2
ROIC/WACC0.18
WACC7.89%
VAS.DE Yearly LT Debt VS Equity VS FCFVAS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

VAS has a Current Ratio of 1.43. This is a normal value and indicates that VAS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.43, VAS is doing worse than 67.57% of the companies in the same industry.
VAS has a Quick Ratio of 1.43. This is a bad value and indicates that VAS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of VAS (0.46) is worse than 86.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.46
VAS.DE Yearly Current Assets VS Current LiabilitesVAS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

The earnings per share for VAS have decreased strongly by -112.74% in the last year.
VAS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.20% yearly.
Looking at the last year, VAS shows a decrease in Revenue. The Revenue has decreased by -5.81% in the last year.
The Revenue has been growing slightly by 4.23% on average over the past years.
EPS 1Y (TTM)-112.74%
EPS 3Y36.89%
EPS 5Y-23.2%
EPS Q2Q%-92.95%
Revenue 1Y (TTM)-5.81%
Revenue growth 3Y15.24%
Revenue growth 5Y4.23%
Sales Q2Q%-1.83%

3.2 Future

Based on estimates for the next years, VAS will show a very strong growth in Earnings Per Share. The EPS will grow by 75.73% on average per year.
The Revenue is expected to decrease by -0.38% on average over the next years.
EPS Next Y159.12%
EPS Next 2Y100.73%
EPS Next 3Y75.73%
EPS Next 5YN/A
Revenue Next Year-5.28%
Revenue Next 2Y-1.82%
Revenue Next 3Y-0.38%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VAS.DE Yearly Revenue VS EstimatesVAS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
VAS.DE Yearly EPS VS EstimatesVAS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VAS. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 10.49, which indicates a very decent valuation of VAS.
Based on the Price/Forward Earnings ratio, VAS is valued a bit cheaper than 67.57% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, VAS is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.49
VAS.DE Price Earnings VS Forward Price EarningsVAS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VAS is valued cheaper than 81.08% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VAS indicates a rather cheap valuation: VAS is cheaper than 89.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.72
EV/EBITDA 4.72
VAS.DE Per share dataVAS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

VAS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VAS's earnings are expected to grow with 75.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100.73%
EPS Next 3Y75.73%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.75%, VAS is a good candidate for dividend investing.
VAS's Dividend Yield is rather good when compared to the industry average which is at 3.77. VAS pays more dividend than 89.19% of the companies in the same industry.
VAS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 5.75%

5.2 History

The dividend of VAS decreases each year by -0.85%.
Dividend Growth(5Y)-0.85%
Div Incr Years3
Div Non Decr Years3
VAS.DE Yearly Dividends per shareVAS.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

The earnings of VAS are negative and hence is the payout ratio. VAS will probably not be able to sustain this dividend level.
DP-187.5%
EPS Next 2Y100.73%
EPS Next 3Y75.73%
VAS.DE Yearly Income VS Free CF VS DividendVAS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

VOESTALPINE AG

FRA:VAS (3/7/2025, 7:00:00 PM)

24.94

-0.56 (-2.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)06-04 2025-06-04/amc
Inst Owners22.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.45B
Analysts75.29
Price Target26.24 (5.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.75%
Yearly Dividend1.49
Dividend Growth(5Y)-0.85%
DP-187.5%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-71.83%
Min EPS beat(2)-77.72%
Max EPS beat(2)-65.94%
EPS beat(4)0
Avg EPS beat(4)-60.93%
Min EPS beat(4)-97.55%
Max EPS beat(4)-2.51%
EPS beat(8)1
Avg EPS beat(8)-35.95%
EPS beat(12)3
Avg EPS beat(12)-20.84%
EPS beat(16)7
Avg EPS beat(16)-8.38%
Revenue beat(2)2
Avg Revenue beat(2)1.69%
Min Revenue beat(2)0.77%
Max Revenue beat(2)2.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.67%
Min Revenue beat(4)-5%
Max Revenue beat(4)2.61%
Revenue beat(8)4
Avg Revenue beat(8)0.34%
Revenue beat(12)7
Avg Revenue beat(12)1.37%
Revenue beat(16)8
Avg Revenue beat(16)0.29%
PT rev (1m)0.42%
PT rev (3m)-10.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-38.34%
EPS NY rev (1m)-24.94%
EPS NY rev (3m)-38.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)-0.69%
Revenue NY rev (3m)-1.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.49
P/S 0.28
P/FCF 12.72
P/OCF 2.98
P/B 0.62
P/tB 0.77
EV/EBITDA 4.72
EPS(TTM)-0.45
EYN/A
EPS(NY)2.38
Fwd EY9.53%
FCF(TTM)1.96
FCFY7.86%
OCF(TTM)8.36
OCFY33.52%
SpS89.82
BVpS40.44
TBVpS32.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.41%
ROE -0.89%
ROCE 2.34%
ROIC 1.4%
ROICexc 1.5%
ROICexgc 1.74%
OM 1.51%
PM (TTM) N/A
GM 17.28%
FCFM 2.18%
ROA(3y)4.84%
ROA(5y)2.66%
ROE(3y)11.5%
ROE(5y)6.24%
ROIC(3y)7.41%
ROIC(5y)N/A
ROICexc(3y)8.31%
ROICexc(5y)N/A
ROICexgc(3y)9.81%
ROICexgc(5y)N/A
ROCE(3y)12.58%
ROCE(5y)N/A
ROICexcg growth 3Y31.13%
ROICexcg growth 5Y4.43%
ROICexc growth 3Y33.13%
ROICexc growth 5Y5.32%
OM growth 3Y15.53%
OM growth 5Y-1.04%
PM growth 3Y16.09%
PM growth 5Y-27.48%
GM growth 3Y-0.15%
GM growth 5Y-3.98%
F-Score5
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 9.89
Debt/EBITDA 1.9
Cap/Depr 106.53%
Cap/Sales 7.12%
Interest Coverage 1.23
Cash Conversion 113.6%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.46
Altman-Z 2.2
F-Score5
WACC7.89%
ROIC/WACC0.18
Cap/Depr(3y)96.81%
Cap/Depr(5y)81.64%
Cap/Sales(3y)5%
Cap/Sales(5y)5.27%
Profit Quality(3y)142.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-112.74%
EPS 3Y36.89%
EPS 5Y-23.2%
EPS Q2Q%-92.95%
EPS Next Y159.12%
EPS Next 2Y100.73%
EPS Next 3Y75.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.81%
Revenue growth 3Y15.24%
Revenue growth 5Y4.23%
Sales Q2Q%-1.83%
Revenue Next Year-5.28%
Revenue Next 2Y-1.82%
Revenue Next 3Y-0.38%
Revenue Next 5YN/A
EBIT growth 1Y-79.91%
EBIT growth 3Y33.13%
EBIT growth 5Y3.15%
EBIT Next Year72.16%
EBIT Next 3Y23.53%
EBIT Next 5Y14.97%
FCF growth 1Y263.22%
FCF growth 3Y-29.27%
FCF growth 5Y24.8%
OCF growth 1Y202.43%
OCF growth 3Y-3.94%
OCF growth 5Y4.42%